For the quarter ended September 2025, CVS Health (CVS) reported revenue of $102.87 billion, up 7.8% over the same period last year. EPS came in at $1.60, compared to $1.09 in the year-ago quarter.
The reported revenue represents a surprise of +4.66% over the Zacks Consensus Estimate of $98.29 billion. With the consensus EPS estimate being $1.36, the EPS surprise was +17.65%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how CVS Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Medical benefit ratio (MBR): 92.8% versus the seven-analyst average estimate of 92.3%.
- Medical membership - Total: 26.7 million compared to the 26.58 million average estimate based on five analysts.
- Medical membership - Commercial - Total: 18.85 million versus the four-analyst average estimate of 18.75 million.
- Medical membership - Medicaid - Total: $2.37 billion versus the four-analyst average estimate of $2.39 billion.
- Revenue- Health Care Benefits: $35.99 billion compared to the $34.82 billion average estimate based on six analysts. The reported number represents a change of +9.1% year over year.
- Revenue- Pharmacy & Consumer Wellness Segment: $36.21 billion versus the six-analyst average estimate of $35.43 billion. The reported number represents a year-over-year change of +11.7%.
- Net revenue- Health Services segment: $49.27 billion versus the six-analyst average estimate of $45.64 billion. The reported number represents a year-over-year change of +11.6%.
- Revenue- Corporate/Other: $133 million versus $125.91 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -6.3% change.
- Revenue- Health Care Benefits Segment- Premiums: $33.74 billion compared to the $32.54 billion average estimate based on four analysts. The reported number represents a change of +9.1% year over year.
- Revenue- Pharmacy & Consumer Wellness Segment- Front store: $5.19 billion compared to the $5.43 billion average estimate based on four analysts. The reported number represents a change of -0.1% year over year.
- Revenue- Pharmacy & Consumer Wellness Segment- Pharmacy: $30.43 billion versus $29.16 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +14.1% change.
- Revenue- Eliminations: $-18.74 billion versus $-17.74 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +31.4% change.
View all Key Company Metrics for CVS Health here>>>
Shares of CVS Health have returned +9% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CVS Health Corporation (CVS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
